Nilanjan Roy

About

Mentor, team builder & motivational leader. Build cluster laboratories successfully to integrate computational biology & molecular modeling with genomics & proteomics for identifying pathways, regulatory proteins, putative drug targets and small molecule agonist/antagonist.

Have PhD degree from one of the oldest institutes in India Bose Institute, Kolkata. Seven years of post PhD research experience from Cleveland Clinic Foundation and Lerner Research Institute, Cleveland, Ohio, USA.

Taught Genomics Proteomics and Systems biology for twelve years and established a strong drug target identification research group at NIPER, Mohali. Established several international collaborations for target specific drug discovery with IBMC in Porto, University of Modena and Robert Gordon University.

Currently working as Director of ARIBAS, responsible for leading the institute to achieve highest academic grade from national and state accreditation agencies. Adviser for writing and presenting scientific proposals and seeking funds from national and international funding sources. Expert in simplification of data management for sustainable development and building Industry-Academia Linkages.

Industry consultant for data mining and data management of omics biology, particularly in area of Biotechnology, Life Sciences and Pharmainformatics. Unique expertise in high throughput omics data analysis strategies.

Employment

• Ashok and Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences Director
  2013 - Present
• National Institute of Pharmaceutical Education and Research Asso Professor
  2006 - 2012
• National Institute of Pharmaceutical Education and Research Asst Prof
  2001 - 2006
• Cleveland Clinic Staff
  1998 - 2001

Education

• Cleveland Clinic Postdoc
  1994 - 1998
• Bose Institute PhD
  1989 - 1994
• University of Kalyani MSc
  1987 - 1989
• Krishnachandra collage BSc Chemistry Hons
  1983 - 1986

Projects & Funding

Projects & funding information is unavailable.

Publications (71)

• QSAR Study of Curcumine Derivatives as HIV-1 Integrase Inhibitors
  Current Computer - Aided Drug Design 2013 DOI: 10.2174/157340913804998793
  +Save
• Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line
  ACAMC 2013 DOI: 10.2174/1871520611313030005
  +Save
• QSAR Study of Curcumine Derivatives as HIV-1 Integrase Inhibitors
  CAD 2013 DOI: 10.2174/1573409911309010013
  +Save
• Knockdown of Asparagine Synthetase A Renders Trypanosoma brucei Auxotrophic to Asparagine
  2013 DOI: 10.1371/journal.pntd.0002578
  +Save
• Marshall and Walras, disequilibrium trades and the dynamics of equilibration in the continuous double auction market
  2013 DOI: 10.1016/j.jebo.2012.12.002
  +Save
• QSAR study of curcumine derivatives as HIV-1 integrase inhibitors
  2013
  +Save
• In silico screening for identification of novel HIV-1 integrase inhibitors using QSAR and docking methodologies
  Med Chem Res 2013 DOI: 10.1007/s00044-013-0490-y
  +Save
• Synthesis and antibacterial evaluation of benzazoles tethered dihydro[1,3]oxazines
  2012
  +Save
• Hepatocyte nuclear factor-1alpha mediated upregulation of albumin expression in focal ischemic rat brain
  neurol res 2012 DOI: 10.1179/1743132811y.0000000052
  +Save
• Identification of Novel HIV-1 Integrase Inhibitors Using Shape-Based Screening, QSAR, and Docking Approach
  Chemical Biology & Drug Design 2012 DOI: 10.1111/j.1747-0285.2012.01326.x
  +Save